Table 2.
Infiltrative cardiomyopathy (n = 11) | HCM (n = 35) | p value | |
---|---|---|---|
Maximum LV wall thickness, mm | 17 ± 3 | 20 ± 4 | 0.021 |
Interventricular wall thickness, mm | 16 ± 3 | 16 ± 4 | 0.628 |
Posterior wall thickness*, mm | 15 ± 3 | 11 ± 2 | <0.001 |
LV end-diastolic diameter*, mm | 44 ± 5 | 44 ± 6 | 0.836 |
LV end-systolic diameter*, mm | 32 ± 7 | 28 ± 7 | 0.118 |
Ejection fraction*, % | 54 ± 13 | 62 ± 13 | 0.104 |
Left atrial diameter, mm | 44 ± 6 | 43 ± 8 | 0.723 |
E*, cm/s | 89 ± 23 | 69 ± 21 | 0.012 |
A, cm/s | 67 ± 33 | 64 ± 19 | 0.704 |
E/A* | 1.7 ± 1.0 | 1.1 ± 0.5 | 0.141 |
Dct*, msec | 208 ± 81 | 200 ± 68 | 0.857 |
Ea septal*, cm/s | 3.9 ± 1.1 | 5.2 ± 2.3 | 0.116 |
Ea lateral*, cm/s | 4.8 ± 1.3 | 8.1 ± 3.5 | <0.001 |
E/Ea septal | 24 ± 7 | 15 ± 7 | <0.001 |
E/Ea lateral* | 20 ± 8 | 10 ± 4 | <0.001 |
Presence of LVOTO, n (%) | 1 (9 %) | 7 (20 %) | 0.658 |
Presence of RVH, n (%) | 6 (55 %) | 18 (51 %) | 0.857 |
Data are shown as mean ± SD or number (percent)
A mark of * is the results of Wilcoxon rank sum test
HCM Hypertrophic cardiomyopathy, LV Left ventricular, LVOTO Left ventricular outflow tract obstruction, RVH Right ventricular hypertrophy